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Sickle Cell Disease in California
Facts for Providers
What is Sickle Cell Disease (SCD)?
 • SCD is a group of inherited conditions that affect hemoglobin, a 
protein that allows red blood cells (RBC) to carry oxygen to all parts of 
the body. 
 • The most common types of SCD are:
 ο Hemoglobin SS Disease (HbSS) - People who have this form of SCD 
inherit two sickle cell hemoglobin genes (“S”), one from each 
parent. This is commonly called sickle cell anemia and is usually the 
most severe form of the disease.
 ο Hemoglobin SC Disease (HbSC) - People who have this form of SCD 
inherit a sickle cell hemoglobin gene (“S”) from one parent and from 
the other parent a gene for abnormal hemoglobin called “C”. This is 
usually a milder form of SCD.
 ο Hemoglobin S beta thalassemia (HbS beta thalassemia) - People 
who have this form of SCD inherit one sickle cell hemoglobin gene 
(“S”) from one parent and one gene for beta thalassemia, another 
type of anemia, from the other parent. There are two types of beta 
thalassemia: “0” and “+”. Those with HbS beta0-thalassemia usually 
have a more severe form of SCD. People with HbS beta+-thalassemia 
tend to have a milder form of SCD.
There were 
approximately 5,100 
people with SCD living in 
California in 2004-2008:
 • 14% younger than 
6 years
 • 25% 6-17 years
 • 22% 18-29 years
 • 28% 30-50 years
 • 11% 51 years 
and older
 There were 486 babies 
born with SCD in 
California in 2004-2008:
 • 89% were Black, 
African-American
 • 8% were Hispanic, 
Hispanic-American
 • 5% were Other
Note: There is overlap between 
the race and ethnicity categories.
SCD affects all races 
and ethnic groups. In 
California, SCD occurs 
among approximately 
1 out of every 
 • 5,644 live births
 • 452 Black, African-
American, live births
 • 35,454 Hispanic-
American live births
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Healthcare utilization by people 
with SCD, 2004-2008
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Emergency Room Visits Hospital Admissions
 • The number of hospital admissions and emergency 
room visits rises dramatically after age 18
Most common medical treatments provided 
to people with SCD on Medi-Cal, 2004-2008
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 • Less than 35% of people with SCD in each age group 
used hyroxyurea during the five years
Most common medical procedures provided 
to people with SCD on Medi-Cal, 2004-2008
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 • Over 40% of people with SCD in each age group 
received at least one transfusion during the five years
Most common complications and comorbidities 
among people with SCD on Medi-Cal, 2004-2008
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 • Pneumonia/Acute Chest Syndrome (ACS) was the most 
common complication across all ages
Total number of hospital days 
for people with SCD, 2004-2008
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 • Over 60% of people with SCD, age 6 and older, spent 
at least 1 day in the hospital during the five years
Age at death for people with SCD, 2004-2008
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 • Over 40% of deaths in people with SCD during the five 
years were 40 years old and younger
These data were collected through the Registry and Surveillance System for 
Hemoglobinopathies (RuSH).  RuSH was a pilot project that was implemented by the 
Centers for Disease Control and Prevention (CDC) in collaboration with the National 
Institutes for Health (NIH), National Heart, Lung, and Blood Institute (NHLBI). 
For more information, please visit 
www.cdc.gov/ncbddd/sicklecell and http://casicklecell.org/
Like us on Facebook at California Sickle Cell Resources
